bioAffinity Technologies, Inc. - Common Stock — Flux de trésorerie (NASDAQ:BIAF) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Flux de trésorerie liés aux activités d'exploitation -4.07 M-6.04 M-7.26 M-9.33 M -10.91 M Flux de trésorerie liés aux activités d'investissement -219.99 K-2.21 M-79.08 K-60.57 K -15.45 K Flux de trésorerie liés aux activités de financement 14.34 M-344.98 K5.63 M14.73 M 13.58 M Flux de trésorerie disponible -4.07 M-6.04 M-7.26 M-9.39 M -10.93 M

Nouvelles

BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath Lung

bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?

bioAffinity Technologies, Inc. (BIAF) Discusses Clinical Integration of CyPath Lung in Pulmonary Nodule Assessment and Early Lung Cancer Diagnosis Transcript

What's Going On With bioAffinity Technologies Stock Wednesday? - bioAffinity Technologies (NASDAQ:BIAF)

Qu'est-ce qui se passe avec les actions de bioAffinity ce jeudi? | Benzinga France

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%

Why Is bioAffinity Technologies Stock Surging Tuesday? - bioAffinity Technologies (NASDAQ:BIAF)

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.25%

bioAffinity Technologies annonce ses résultats financiers 2025

bioAffinity Technologies reports 2025 financial results

bioAffinity Technologies Stock Soars 120% On CyPath Lung Sales Growth - bioAffinity Technologies (NASDAQ:BIAF)

BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now?